Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueNotes PayablesOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Nuvation Bio (NUVB) Accumulated Depreciation (2023 - 2024)

Historic Accumulated Depreciation for Nuvation Bio (NUVB) over the last 2 years, with Q4 2024 value amounting to $874000.0.

  • Nuvation Bio's Accumulated Depreciation rose 3123.12% to $874000.0 in Q4 2024 from the same period last year, while for Dec 2024 it was $874000.0, marking a year-over-year increase of 3123.12%. This contributed to the annual value of $874000.0 for FY2024, which is 3123.12% up from last year.
  • Nuvation Bio's Accumulated Depreciation amounted to $874000.0 in Q4 2024, which was up 3123.12% from $666000.0 recorded in Q4 2023.
  • In the past 5 years, Nuvation Bio's Accumulated Depreciation ranged from a high of $874000.0 in Q4 2024 and a low of $666000.0 during Q4 2023